HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia.

Abstract
We attempted percutaneous transluminal renal angioplasty in 89 patients with hypertension and renal-artery stenosis (including 51 with atheromatous and 31 with fibromuscular stenoses) who were then followed for an average of 16 months (range, 4 to 40). Angioplasty was technically successful in 87 per cent of the fibromuscular stenoses and in 57 per cent of the unilateral atheromatous stenoses but in only 10 per cent of the bilateral atheromatous stenoses. After successful angioplasty, blood pressure was reduced to normal or improved in 93 per cent of the patients with fibromuscular dysplasia and in 84 per cent of the patients with atheromatous disease. Angiographic follow-up at an average of 21.8 months in 15 patients showed persistent relief of the stenoses and a 12 per cent average increase in kidney size. Renal angioplasty is effective for long-term control of hypertension in patients with renal-artery stenosis due to fibromuscular dysplasia or unilateral non-ostial atheroma.
AuthorsT A Sos, T G Pickering, K Sniderman, S Saddekni, D B Case, M F Silane, E D Vaughan Jr, J H Laragh
JournalThe New England journal of medicine (N Engl J Med) Vol. 309 Issue 5 Pg. 274-9 (Aug 04 1983) ISSN: 0028-4793 [Print] United States
PMID6223227 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Angioplasty, Balloon (methods)
  • Arterial Occlusive Diseases (complications)
  • Arteriosclerosis (complications)
  • Blood Pressure
  • Fibromuscular Dysplasia (complications)
  • Follow-Up Studies
  • Humans
  • Hypertension, Renal (therapy)
  • Hypertension, Renovascular (etiology, physiopathology, therapy)
  • Kidney (pathology, physiopathology)
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: